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Host- and pathogen-associated cytoplasmic double-strandedDNA
triggers the activation of a NALP3 (also known as cryopyrin and
NLRP3)-independent inflammasome1, which activates caspase-1
leading to maturation of pro-interleukin-1b and inflammation.
The nature of the cytoplasmic-DNA-sensing inflammasome is
currently unknown. Here we show that AIM2 (absent in mela-
noma 2), an interferon-inducible HIN-200 family member that
contains an amino-terminal pyrin domain and a carboxy-terminal
oligonucleotide/oligosaccharide-binding domain2,3, senses cyto-
plasmic DNA by means of its oligonucleotide/oligosaccharide-
binding domain and interacts with ASC (apoptosis-associated
speck-like protein containing a CARD) through its pyrin domain
to activate caspase-1. The interaction of AIM2 with ASC also leads
to the formation of the ASC pyroptosome4, which induces pyrop-
totic cell death in cells containing caspase-1. Knockdown of AIM2
by short interfering RNA reduced inflammasome/pyroptosome
activation by cytoplasmic DNA in human and mouse macro-
phages, whereas stable expression of AIM2 in the non-responsive
human embryonic kidney 293T cell line conferred responsiveness
to cytoplasmic DNA. Our results show that cytoplasmic DNA
triggers formation of the AIM2 inflammasome by inducing
AIM2 oligomerization. This study identifies AIM2 as an important
inflammasome component that senses potentially dangerous cyto-
plasmic DNA, leading to activation of the ASC pyroptosome and
caspase-1.
A key innate immune response against infection with microbial or
viral pathogens and tissue damage is the rapid activation of multi-
protein complexes called inflammasomes5. The inflammasomes
activate caspase-1, a cysteine protease that processes the inactive
pro-interleukin-1b (pro-IL1b) and pro-IL18 to their active pro-
inflammatory cytokines IL1b and IL18, respectively. Themost studied
among these is the NALP3 inflammasome5, which is activated by
diverse stimuli perhaps by a lysosomal destablization mechanism6,7.
A recent study showed thatDNA fromdifferent sources activates an
ASC-dependent, but a NALP3-independent, inflammasome1. To
identify theDNA-sensing inflammasome,we searched theNCBI data-
base for proteins with pyrin and oligonucleotide-binding domains.
We identified four human proteins (IFI16, AIM2, IFIX and MNDA),
which belong to the interferon-inducibleHIN-200 family2,3, thatmeet
these two criteria. Investigation of the ability of these proteins to
activate caspase-1 when ectopically expressed in the stable 293T-
caspase-1-ASC cell line8 (293T cell line containing caspase-1 and
ASC) showed that AIM2 is the only member of the HIN-200 family
capable of activating caspase-1 (Fig. 1a and Supplementary Fig. 1).
The activation of caspase-1 byAIM2was dependent on an intact pyrin
domain (PYD) because deletion of the PYD of AIM2 completely
abrogated caspase-1 activation (Fig. 1b). This was also dependent
on ASC, because noAIM2-induced caspase-1 activationwas observed
in the 293T-caspase-1 cells8, which lack ASC (Fig. 1a and Supple-
mentary Fig. 1a). Additionally, expression of AIM2 induced secretion
of activated caspase-1 and IL1b from stable 293T-caspase-1-ASC-
pro-IL1b cells, which express ASC, but not from 293T-caspase-1-
pro-IL1b cells, which lack ASC (Fig. 1c). Together, these results indi-
cate that AIM2 can activate caspase-1 to produce the active IL1b
cytokine in an ASC-dependent manner, perhaps by engaging ASC
and inducing its oligomerization. Indeed, expression of AIM2 in
293T-ASC–EGFP-N1 cells8 (293T cell line containing enhanced green
fluorescent protein (EGFP)-tagged ASC) resulted in the formation of
the oligomeric ASCpyroptosome that we showed recently to particip-
ate in caspase-1 activation during pyroptosis4 (Fig. 1d and Supple-
mentary Fig. 2).
To gain some insight into how AIM2 induces ASC-dependent
caspase-1 activation, we tested whether AIM2 interacts directly with
ASC to activate caspase-1. In vitro pull-down experiments revealed
that full-length AIM2, but not a truncated AIM2 lacking the PYD
(AIM2-DPYD), can interact with ASC and its isolated PYD (Fig. 2a,
b). Furthermore, immunoprecipitation of endogenous ASC from
interferon-c-induced human THP-1 cell lysates with an ASC-specific
antibody resulted in precipitation of endogenous AIM2 (Fig. 2c). No
detectable interaction between ASC and endogenous IFI16, MNDA
or IFIX was observed (Fig. 2c, fourth to sixth panels from the top),
further supporting our earlier conclusion that only AIM2, among
members of the HIN-200 family, can specifically interact with ASC
to activate caspase-1. Together, these results indicate that AIM2
associates directly with ASC by means of PYD–PYD interactions.
This interaction is reminiscent of the interaction of NALP3 or pyrin
with the PYD of ASC, which induces ASC oligomerization leading to
activation of caspase-1 in response to various stimuli8–10.
Structural analysis of the C-terminal HIN-200 domain of AIM2
revealed that this domain contains two adjacent oligonucleotide/oli-
gosaccharide-binding folds11 that could potentially interact with
DNA. Electrophoretic mobility shift assays with purified HIN-200
domain of AIM2 (AIM2-DPYD; Supplementary Fig. 4a, left panel)
and the synthetic DNA poly(dA-dT)Npoly(dA-dT) (referred to
throughout as poly(dA:dT)) showed formation of increasing
amounts of slow-migrating AIM2–DNA complexes with increasing
amounts of AIM2-DPYD (Supplementary Fig. 4a, right panel), indi-
cating that this domain can indeed bind to DNA. As expected, a
purified full-length AIM2, but not the isolated PYD, was also capable
of binding to DNA and inducing a gel-shift of poly(dA:dT)
(Supplementary Fig. 4b).
Given that AIM2 can interact with ASC and DNA through its PYD
and HIN-200 domains, respectively, we next used AIM2-targeting
short interfering RNA (siRNA) to demonstrate that AIM2 has an
important role in caspase-1 activation by cytoplasmic DNA.
Knocking down human AIM2 in THP-1 cells clearly reduced
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poly(dA:dT)-induced caspase-1 activation and IL1b processing
(Fig. 2d, fourth lane, and Supplementary Fig. 5a, b). Knocking down
AIM2 had little effect on caspase-1 and IL1b activation by mono-
sodium urate (MSU), which activates caspase-1 through the NALP3
inflammasome (Fig. 2d, fifth and sixth lanes). Consistent with these
results, knocking down mouse AIM2 in immortalized wild-type and
NALP32/2 mouse bone marrow macrophages also significantly
reduced poly(dA:dT)-induced caspase-1 activation (Fig. 2e and
Supplementary Fig. 6a–c). The Aim2-targeting siRNAs had little
effect on caspase-1 activation by lipopolysaccharide (LPS) plus
ATP in mouse wild-type macrophages (Supplementary Fig. 6d and
Supplementary Note 1). Together, these results indicate that AIM2 in
human andmousemacrophages senses cytoplasmic DNA through its
HIN-200 domain and is critical for caspase-1 activation by cytoplas-
mic DNA.
A pyroptosome formation assay in THP-1-ASC–EGFP-N1 cells4
revealed that cytoplasmic DNA induces robust ASC oligomerization
(Fig. 3a). To provide direct evidence that AIM2 is required for DNA-
induced ASC oligomerization, we used 293T cells, which do not
express endogenous AIM2 (Supplementary Fig. 7a), to generate a
stable 293T cell line that co-expresses AIM2 and ASC–EGFP proteins
(designated 293T-AIM2-ASC–EGFP-N1). Transfection with
poly(dA:dT) induced ASC pyroptosome formation in 293T-AIM2-
ASC–EGFP-N1 cells within 2 h after transfection (Fig. 3b, lower right
panel), but not in control 293T-ASC–EGFP-N1 cells, which do not
express AIM2 (Fig. 3b, lower left panel). Quantification of the ASC
pyroptosomes revealed a dose-dependent effect of poly(dA:dT) in
these cells (Fig. 3c). Consistent with these results, DNA fromdifferent
sources including poly(dA:dT) (Supplementary Note 2) was able to
induce caspase-1 activation in a stable 293T-caspase-1-ASC-AIM2
cell line that co-expresses pro-caspase-1, ASC and AIM2, but not in
the parental 293T-caspase-1-ASC cell line, which lacks AIM2
(Fig. 3d). The expression level of AIM2 in the 293T-caspase-1-
ASC-AIM2 cells is comparable to the expression of endogenous
AIM2 in interferon-c-induced THP-1 cells (Fig. 3e). Transfection
of plasmid DNA into a stable 293T-caspase-1-ASC-NALP3 cell line
that co-expresses pro-caspase-1, ASC and NALP3 did not induce
caspase-1 activation, indicating that, unlike AIM2, NALP3 does
not participate directly in sensing cytoplasmic DNA (Fig. 3f).
These results underscore the essential role of AIM2 in cytoplasmic
DNA sensing and DNA-induced ASC oligomerization and caspase-1
activation, and indicate that binding of cytoplasmic DNA to AIM2
generates the molecular signal necessary for this process to occur.
To understand how cytoplasmic DNA induces AIM2 activation,
we tested the ability of purified recombinant human AIM2 to induce
activation of a chimaeric PYD–caspase-1 protein, which contains an
N-terminal PYD derived fromASC instead of the CARD, in vitro (see
Supplementary Note 3). Incubation of purified AIM2 or ASC pyro-
ptosome with PYD–caspase-1 resulted in its activation (Fig. 4a,
second and fourth lanes, respectively). No activation of PYD–
caspase-1 was seen when it was incubated with AIM2-DPYD, which
lacks the PYD (third lane), indicating that the interactions of the PYD
of AIM2 with the PYD of PYD–caspase-1 is required for activation.
AIM2 was also able to activate a chimaeric wild-type PYD–caspase-9,
but not an active site mutant PYD–caspase-9(C287A) (Fig. 4b).
Because initiator pro-caspases are activated by dimerization, these
results indicate that AIM2 activates the pro-caspase-1 and pro-cas-
pase-9 chimaeras by inducing the dimerization of their inactive
monomeric forms. Unexpectedly, incubation of AIM2 with
poly(dA:dT) did not increase the ability of AIM2 to activate PYD–
caspase-9 or PYD–caspase-1 (Fig. 4c and data not shown). This indi-
cates that the purified AIM2 might have already been activated by
bacterial DNA during expression in bacteria or self-oligomerized
during purification. Indeed, chemical cross-linking experiments in
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Figure 1 | Activation of caspase-1 by AIM2. a, b, The indicated cells
(13 106 cells per 35-mm well) were transfected with 0.5 mg of an empty
vector (Vec) or constructs encoding human AIM2, IFI16 or pyrin (a), or
with Vec, full-length (FL) AIM2 or AIM2-DPYD plasmids (b), as indicated
for 24 h. Lysates were analysed by western blotting (WB) with anti-Flag
antibody (first panel from the top) or anti-caspase-1 p30 polyclonal
antibody (second panel). The blot in a was re-probed with IFI16, AIM2,
pyrin or ASC antibodies (third to sixth panels, respectively). c, Immunoblots
for caspase-1 (top panel), IL1b (middle panel) and IL1b p17 (bottom panel)
in culture supernatants of the indicated cell lines transfected with the
indicated amounts of AIM2 expression plasmid. d, Percentages of ASC
pyroptosomes in 293T-ASC–EGFP-N1 cells after transfection with the
indicated plasmids. Values represent mean and s.d. (n5 4); *P, 0.05,
**P, 0.01, ***P, 0.005.
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the absence of DNA showed that the purified AIM2 preparation
contains dimeric and oligomeric forms of AIM2 (Fig. 4d, second
lane). Interestingly, cross-linking in the presence of DNA increased
the oligomeric forms of AIM2 (Fig. 4d, third and fourth lanes) in a
dose-dependent manner, as evidenced by the formation of very large
AIM2 oligomers that failed to enter the gel. This result indicates that
binding of double-stranded DNA to AIM2 induces its oligomeriza-
tion, which explains the ability of cytoplasmic DNA to activate the
AIM2 inflammasome in macrophages and in AIM2-reconstituted
293T cells.
To provide direct evidence that cytoplasmic DNA can indeed
induce AIM2 oligomerization, we transfected 293T-AIM2–EGFP-
N1 cells or NALP32/2-AIM2–EGFP-N1 mouse macrophages cells
that stably express human or mouse EGFP-tagged AIM2, respec-
tively, with a Cy3-labelled plasmid DNA. Confocal live cell imaging
revealed that DNA induced notable clustering of the cytoplasmic
AIM2–EGFP around the transfected DNA in both 293T cells and
NALP32/2 macrophages (Fig. 5b, d and Supplementary Fig. 9).
DNA did not induce clustering of free EGFP in the control 293T-
EGFP cells (Fig. 5a), indicating that AIM2 is responsible for the
clustering of AIM2–EGFP in the 293T andNALP32/2macrophages.
Interestingly, DNA-induced clustering of AIM2–EGFP caused pyro-
ptotic cell death with characteristic plasmamembrane swelling in the
NALP32/2-AIM2–EGFP-N1 cells (Fig. 5d, Supplementary Fig. 10
and Supplementary Movie 1), but not in the 293T-AIM2–EGFP-
N1 cells (Fig. 5b), because these cells lack ASC and caspase-1. Pre-
treatment of the NALP32/2-AIM2–EGFP-N1 cells with the caspase
inhibitor zVAD-FMK (Z-Val-Ala-Asp-Fluoromethyl ketone) did not
affect DNA-induced clustering of AIM2–EGFP in these cells, but
prevented cell death (Supplementary Fig. 9b). Taken together, these
results provide direct evidence that cytoplasmic DNA binds to AIM2
and induces its oligomerization in live cells. This is the first demon-
stration of an inflammasome bound to its ligand in live cells.
Theputative tumour-suppressive activity ofAIM2 (ref. 12)might be
attributed to its ability to induce pyroptosis in cells that co-expressASC
and pro-caspase-1. Indeed, transient expression of AIM2 in 293T-
ASC-caspase-1 cells resulted in pyroptotic cell death as measured by
the release of lactate dehydrogenase (LDH) in the culture medium
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Figure 2 | AIM2 interacts with ASC to activate caspase-1.
a, b, Immunoblots showing in vitro association of ASC–GST (glutathione
S-transferase) and ASC-PYD–GST with full-length AIM2 (top panel), but
not with truncated AIM2-DPYD (middle panel) (a), and in vitro association
ofAIM2–GSTwith full-lengthASC (b). The bottompanels showCoomassie-
stained gel of the GST-tagged proteins used in the pull-down assay (see
Supplementary Fig. 3). GST–ASC-CARD refers to the isolatedCARDof ASC
fused to GST. c, Association of endogenous ASC with endogenous AIM2 in
THP-1 cell lysate detected by immunoprecipitation (IP, first lanes, left
panels) with an ASC-specific monoclonal antibody as described in the
Methods. IP with an Omi-specific monoclonal antibody was used as a
negative control (second lanes, left panels). d, e, Immunoblots of lysates and
culture supernatants of THP-1 cells (d) or mouse wild-type and NALP32/2
bone marrow macrophages (e) transfected with AIM2-targeting siRNA
(siAIM2) or control non-specific siRNA (siCon) followed by transfection
with poly(dA:dT) or treatment with MSU as indicated. mcaspase-1, mouse
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Figure 3 | Cell-based reconstitution of the AIM2 inflammasome.
a, Percentages of ASC pyroptosomes in untransfected (none) or
poly(dA:dT)-transfected THP-1 cells. Values represent mean and s.d.
(n5 3). b, Fluorescence confocal images showing formation of the speck-like
ASC pyroptosomes only in 293T-AIM2-ASC–EGFP-N1 cells (right panels),
but not in 293T-ASC–EGFP-N1 cells (left panels), 2 h after transfection with
vehicle (control, top panels) or poly(dA:dT) (bottom panels). DIC,
differential interference contrast. c, Percentages of ASC pyroptosomes in the
indicated cell lines after transfection with poly(dA:dT) for 2 h. Values
represent mean and s.d. (n5 7); *P, 0.005, **P, 0.001. d, Immunoblot
for caspase-1 in lysates from 293T-caspase-1-ASC (lanes 1–5) or 293T-
caspase-1-ASC-AIM2 (lanes 6–10) cells after transfection with the indicated
types of DNA (0.5mg per 13 106 cells) for 24 h. e, Immunoblot for AIM2
(top panel) or Omi (bottom panel) in lysates from uninduced (lane 1) or
interferon-c-induced (IFN-c, lane 2) THP-1 cells, or 293T-caspase-1-ASC-
AIM2 cells (lane 3). f, Immunoblot for caspase-1 in lysates from 293T-
caspase-1-ASC (lanes 1–4) or 293T-caspase-1-ASC-NALP3 (lanes 5–8) cells
after transfection with the indicated plasmid DNA (0.5 mg per 13 106 cells)
for 24 h.
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(Supplementary Fig. 11a). No AIM2-induced cell death was observed
in cells that lack caspase-1orASC(such as293T-caspase-1, 293T-ASC–
EGFP-N1 or 293T-AIM2–EGFP-N1 cells; Fig. 5b, Supplementary
Fig. 11a and data not shown). Consistent with this, transfection of
poly(dA:dT) or plasmid DNA into the NALP32/2 bone marrow
macrophages induced ASC pyroptosome formation (Fig. 5e), cell
death with characteristic features of pyroptosis (Supplementary
Fig. 11b, lower panels, and Supplementary Movie 1) and release of
LDH into the culture medium (Fig. 5f). Knocking down AIM2 by
Aim2-specific siRNA significantly reduced cell death and LDH release
in these cells (Fig. 5f). These data indicate that AIM2 is a bona fide
activator of inflammation and caspase-1-dependent cell death (pyrop-
tosis) in cells that express both ASC and caspase-1.
Our work clearly identifies AIM2 as a major activator of caspase-1
in response to cytoplasmic DNA. As demonstrated in vitro and in live
cells,DNAbindsdirectly toAIM2and induces its oligomerization.We
suggest that the oligomericAIM2–DNAcomplex serves as amolecular
platform, much like the oligomeric NALP3 platform, to recruit ASC
and facilitate the self-association of its PYD to form ASC dimers,
which subsequently oligomerize with other ASC dimers to form a
large structure we called recently the ‘ASC pyroptosome’4. This is
supported by our observation that engagement of AIM2 by cytoplas-
mic DNA leads to the formation of ASC pyroptosomes in THP-1 and
NALP32/2 macrophages and in 293T-AIM2-ASC–EGFP-N1 cells
(Figs 3 and 5). Cytoplasmic DNA, whether derived from infection
with viral or microbial pathogens, tissue damage or delivered by cati-
onic liposomes, is a strong activator of type I interferon response.
AIM2 is an interferon-inducible protein and we have observed upre-
gulation of AIM2 in THP-1 macrophages after treatment with inter-
feron-c, LPS or transfection with the synthetic DNA poly(dA:dT).
Ourdata indicate that the inductionofAIM2 serves as a backup innate
immune response to the NALP3 inflammasome, capable of sensing
cytoplasmic DNA and of triggering a strong pro-inflammatory
response. The perceived redundancy in the response to DNA by the
NALP3 and AIM2 inflammasomes could be explained by differences
in the mechanisms by which these two inflammasomes are activated.
Recent studies indicate that the NALP3 inflammasome is activated by
many stimuli that cause phagosomal/lysosomal destabilization6,7,13–15.
When DNA viruses (for example, adenovirus) infect macrophages, the
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Figure 4 | In vitro reconstitution of the AIM2 inflammasome.
a, Immunoblot for caspase-1 (top panel) or IL1b (bottom panel) after in
vitro incubation of PYD–caspase-1 and pro-IL1b with purified GST–AIM2
(lane 2), GST–AIM2-DPYD (lane 3) or ASC pyroptosome (lane 4).
b, c, Autoradiograms of 35S-labelled wild-type or C287A chimaeric
PYD–caspase-9 after in vitro incubation with purified GST–AIM2 (lanes 2
and 6), GST–AIM2-DPYD (lanes 3 and 7) or ASC pyroptosome (lanes 4 and
8) (b) or with the indicated amounts of purified GST–AIM2 in the presence
or absence of the indicated amounts of poly(dA:dT) (c). d, Immunoblot for
AIM2 after cross-linking of purified AIM2 (2 mg) with glutaraldehyde in the
presence of the indicated amounts of 64-mer double-stranded (ds)DNA. A
longer exposure of this gel is shown in Supplementary Fig. 8.
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DNA-containing viral particles accumulate in the phagosomes16, which
could lead to destablization of the phagosome thereby resulting in
activation of NALP3 as has recently been shown1. In contrast, when
DNA escapes the phagosomes it could be sensed directly by AIM2,
which is induced by the initial type I interferon response to viral entry,
bymeans of direct interactionwith its oligonucleotide/oligosaccharide-
binding-fold-containing domain, thereby leading to AIM2 oligomeri-
zation and activation. It is therefore probable that theNALP3 andAIM2
inflammasomes represent two important lines of defence to ensure a
full pro-inflammatory response to potentially dangerous cytoplasmic
DNA. Additional discussion is provided in the Supplementary
Discussion.
METHODS SUMMARY
Assay of caspase-1 activation. All cells were seeded in 35-mm 6-well plates.
Stimulation with DNA (poly(dA:dT), plasmid, genomic or bacterial) were
performed in serum-free (SF) OPTI-MEMI by cationic liposome transfection
using Lipofectamine 2000 (3.5mlml21), as per the manufacturer’s protocol
(Invitrogen). After stimulation, cell culture supernatants and cell pellets were ana-
lysed by immunoblotting with anti-caspase-1- and anti-IL1b-specific antibodies.
siRNA knockdown. THP-1 cells, or immortalized wild-type or NALP32/2
macrophages, were attached to 35-mm 6-well plates. Cells were then transfected
with siRNA oligonucleotides (50 nM) for 24 h using Lipofectamine 2000 in 2ml
of SF OPTI-MEM I. The next day, cells were washed with SF OPTI-MEMI and
then transfected with poly(dA:dT) (1mgml21) for 6 h with Lipofectamine 2000
in 2ml of SF OPTI-MEMI. The culture supernatants and cells were separated
and then processed for immunoblot analysis with anti-caspase-1- and anti-IL1b-
specific antibodies.
Full Methods and any associated references are available in the online version of
the paper at www.nature.com/nature.
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METHODS
Cell culture.Human293TandTHP-1 cell lineswere purchased fromATCC. 293T
cells were maintained in DMEM/F12 (GIBCO) supplemented with 10% FBS and
100Uml21 penicillin and streptomycin. THP-1 cells were grown in RPMI 1640
(GIBCO) supplemented with 10%FBS, 2mML-glutamine, 10mMHEPES, 1mM
sodium pyruvate, 1.5 g l21 sodium bicarbonate, 0.05mM 2-mercaptoehanol and
100Uml21 penicillin and streptomycin. The v-myc and v-raf immortalizedmouse
wild-type,ASC2/2 andNALP32/2macrophages (gift fromE. Latz) were grown in
DMEM (GIBCO) supplemented with 10% FBS, 100Uml21 penicillin and strep-
tomycin. All cells were grown at 37 uC with 5% CO2. Before stimulation, THP-1
cells were differentiated for 3 h with 0.5–1mMPMA, washed and allowed to attach
to culture dishes for 24h. All experiments for immunoblot analysis of cell culture
supernatants used SF OPTI-MEMImedium (GIBCO). Transfection experiments
with the synthetic poly(dA:dT) DNA or other types of DNA (plasmid, genomic or
bacterial) were performed using Lipofectamine 2000 (3.5mlml21) as per the
manufacturer’s protocol (Invitrogen).
Antibodies and reagents. Mouse polyclonal anti-human AIM2 antibody was
purchased from Abnova. This antibody can detect overexpressed AIM2 but not
endogenous AIM2. The mouse monoclonal anti-human AIM2 antibody (3B10)
used to detect endogenous AIM2 in THP-1 cell lysates was obtained from R.
Johnstone. The anti-human IFI16 monoclonal (sc-8023) and anti-human
MNDA polyclonal (sc-6051) antibodies were obtained from Santa Cruz
Biotechnology. The anti-human IFIX polyclonal antibody was obtained from
M.-C. Hung. The anti-IL1bmonoclonal antibody (32D) was obtained from the
NCI preclinical repository, biological resource branch. Rabbit polyclonal anti-
humanmature (17 kDa) IL1b (Asp 116)was obtained fromCell Signaling. Other
antibodies used against human ASC (anti-human ASC monoclonal; from J.
Sagara), human caspase-1 p30 (anti-human caspase-1, residues 100–404; our
laboratory) and mouse caspase-1 p20 (anti-mouse caspase-1 p20; from J. Yuan)
have been described previously4,8. Poly(dA:dT) sodium salt was from Sigma-
Aldrich. CytoTox96 LDH-release kit was from Promega. The Cy3-labelled plas-
mid DNA (MIR 7904) was obtained from Mirus Bio, LLC.
Full-length cDNAs and expression constructs. The pCMV-sport6 mammalian
expression plasmids for human full-length AIM2 (IMAGE:30367168), IFIX
(IMAGE:5212268) and MNDA (IMAGE:5223430) were obtained from Open
Biosystems and their sequences were verified by automated DNA sequencing.
pcDNA3-IFI16 plasmid was a gift from T. Ouchi. pcDNA3-AIM2-T7 and
pcDNA3-AIM2-DPYD-T7were generated by cloning PCR-generated full-length
AIM2 or AIM2-DPYD cDNAs, respectively, in a modified pcDNA3-T7 plasmid
in frame with a C-terminal T7 tag. For stable expression of a C-terminal EGFP-
tagged human or mouse AIM2 in 293T cells or in mouse NALP32/2 immorta-
lized macrophages, the AIM2 cDNAs were fused in-frame with EGFP cDNA in
the pEGFP-N1 plasmid. The AIM2–EGFP fusion cDNAs were then excised from
the pEGFP-N1 plasmids and subcloned into the pMSCVpuro retroviral transfer
vector to generate the pMSCVpuro-hAIM2–EGFP-N1 and pMSCVpuro-
mAIM2–EGFP-N1 vectors. For expression of AIM2 or AIM2-DPYD with a
His6 or GST tag in bacteria, PCR-generated full-length AIM2 or AIM2-DPYD
cDNAs were inserted into the bacterial expression vector pET-21a (1) in-frame
with a C-terminal His6 or GST tag. Bacterial expression constructs for GST-
tagged ASC, ASC-PYD or ASC-CARD were described previously17. The mam-
malian expression plasmids for full-length human pyrin were described previ-
ously (pcDNA-pyrin-myc-HisB)9.
Generation of stable cell lines. 293T-caspase-1, 293T-caspase-1-ASC and 293T-
ASC–EGFP-N1 cell lines have been described previously4,8,9. Stable 293T-caspase-
1-pro-IL1b or 293T-caspase-1-ASC-pro-IL1b were generated by transfecting
293T-caspase-1 or 293T-caspase-1-ASC, respectively, with dual expression plas-
mid pMSCVgfp-pro-IL1b. Stable cell lineswere obtained aftermultiple cell sorting
over a period of one month by flow cytometry as described before8. Stable 293T-
caspase-1-ASC-AIM2 cells were generated by transfecting 293T-caspase-1-ASC
with dual expression plasmid pRSC-GFP-AIM2 followed by sorting as above.
Stable 293T-AIM2-ASC–EGFP-N1 cell line was generated by co-transfecting
293T cells with pMSCVpuro-ASC–EGFP-N18 and pcDNA3-AIM2-T7 plasmids
at a 1:4 ratio, followed by cell sorting as above and selection in Geneticin (G418,
GIBCO)-andpuromycin-containingmedium.Stable 293T-AIM2–EGFP-N1cells,
expressing the human AIM2–EGFP fusion protein, were generated by transfecting
293T cells with pMSCVpuro-hAIM2–EGFP-N1 expression plasmid followed by
cell sorting as described previously and selection with puromycin-containing
medium. Stable NALP32/2-AIM2–EGFP-N1, which express the mouse AIM2–
EGFP fusion protein, were generated by infecting the NALP32/2 immortalized
macrophages with pMSCVpuro-mAIM2–EGFP-N1 retroviral vector followed by
cell sorting as above and selection with puromycin containing medium.
siRNA knockdown. Human AIM2-targeting siRNA oligonucleotides (AIM2
Stealth Select RNAi, catalogue number 1299003) were obtained from
Invitrogen. The sequences of each siRNA oligonucleotide in this pool are as
follows: hAIM2-HSS114049, 59-UAUGGUGCUAUGAACUCCAGAUGUC-39;
hAIM2-HSS114050, 59-UUUCAGCUUGACUUAGUGGCUUUGG-39; hAIM2-
HSS114051, 59-UUCUCUGAUAGAUUCCUGCUGGGCC-39. Mouse Aim2-
targeting siRNA oligonucleotides (ON-TARGETplus SMARTpool) were
obtained from Dharmacon. The sequences of each siRNA oligonucleotide in this
pool are as follows: mAim2 J044968-09, 59-ACAUAGACACUGAGGGUAU-39;
mAim2 J044968-10, 59-UGUCUAAGGCUUGGGAUAU-39;mAim2 J044968-11,
59-CUACCUGAGGAUAGCAUUU-39; mAim2 J044968-12, 59-AGUACUAAG-
AAAUCAGUGA-39. Non-targeting control siRNA oligonucleotides (AllStars
Neg. Control siRNA, catalogue number 1027281) were obtained from Qiagen.
For AIM2 knockdown experiments in the human THP-1 cell line, cells were
seeded in 35-mm 6-well plates at a density of 23 106 cells per well in the presence
of 1mM PMA and allowed to attach to culture dishes for 3 h. Cells were then
washed and treated with LPS (2mgml21) for 16 h to induce differentiation. The
differentiated cellswere then transfectedwith siRNAoligonucleotides (50 nm) for
24 h using Lipofectamine 2000 (3.5mlml21) in 2ml of SFOPTI-MEMImedium.
The next day, cells were washed with SF OPTI-MEM I medium and then trans-
fected with poly(dA:dT) for 6 h with Lipofectamine 2000 in 2ml of SF OPTI-
MEMI. The culture supernatants and cells were separated and then processed for
immunoblot analysis. For AIM2 knockdown experiments in the immortalized
mouse macrophages, cells were seeded in 6-well plates at a density of 23 106 cells
per well in SF OPTI-MEMImedium and allowed to attach for 2 h. The cells were
then transfected with siRNA oligonucleotides (50 nM) for 24 h using
Lipofectamine 2000 in 2ml of SF OPTI-MEM Imedium. The next day, cells were
washed with SF OPTI-MEMI medium and then transfected with poly(dA:dT)
(1mgml21) for 6 h with Lipofectamine 2000 in 2ml of SF OPTI-MEM I. The
culture supernatants and cells were separated and then processed for immunoblot
analysis.
Immunoblot analysis. Cell culture supernatants were precipitated by the addi-
tion of an equal volume of methanol and 0.25 volumes of chloroform as
described previously7. The supernatant/methanol/chloroform mixtures were
vortexed and then centrifuged for 10min at 20,000g. The upper phase was dis-
carded and 500ml methanol was added to the interphase. This mixture was
centrifuged for 10min at 20,000g and the protein pellet was dried at 55 uC,
resuspended in Laemmli buffer and boiled for 5min at 99 uC. Samples were
separated by 12.5% SDS–PAGE and were transferred onto nitrocellulose mem-
branes. Blots were probedwith rabbit polyclonal antibody to the human caspase-
1 p30, rabbit polyclonal antibody to human cleaved IL1b (Asp116; Cell
Signaling) or rat monoclonal-anti-mouse caspase-1 p20 antibody (a gift from
J. Yuan). Total cell lysates were mixed with SDS sample buffer, fractionated on
12.5% SDS–PAGE and then immunoblotted as described previously.
Immunoprecipitation and in vitro GST pull-down assays. THP-1 cells (107
cells) were treated with IFN-c (75 ngml21) for 24 h and then lysed in 250ml
buffer A (20mM HEPES, pH 7.5, 50mM KCl, 150mM NaCl, 1.5mM MgCl2,
1mM EGTA, 0.5% NP-40, 1mM DTT, 0.2mM PMSF, 2mgml21 aprotinin,
5mMNaF, 1mMNa3VO4). The cell lysate was centrifuged at 20,000g to remove
cell debris. The supernatant was diluted twice with a hypotonic lysis buffer
(10mMHEPES, pH 7.8, 10mMKCl, 2mMMgCl2, 0.1mMEDTA and protease
inhibitor) and then immunoprecipitaed with anti-human ASC or anti-human
Omi mouse monoclonal antibodies at 4 uC. The protein–antibody complexes
were then precipitated with protein G-sepharose bead, and the bead-bound
complexes and lysates were then fractionated by SDS–PAGE followed by immu-
noblotting with anti-AIM2 (3B10) or anti-IFI16 mouse monoclonal antibodies,
or anti-ASC, anti-Omi, anti-MNDAor anti-IFIX rabbit polyclonal antibodies. In
vitro pull-down assays were performed with recombinant bacterially expressed
GST-tagged full-length human ASC, ASC-PYD or ASC-CARD and C-terminal
His6-tagged human AIM2 or AIM2-DPYD. The GST-tagged proteins were iso-
lated from bacterial lysates by glutathione-affinity purification on glutathione-
agarose beads. The bead-bound proteins were then incubated for 2 h at 4 uCwith
bacterially produced His6-tagged AIM2 or AIM2-DPYD proteins. After incuba-
tion, the complexes were fractionated by SDS–PAGE and detected by immuno-
blotting with anti-His6-HRP antibody. Similarly GST-tagged AIM2 or AIM2-
DPYDwas allowed to interactwith bacterially producedASC and the boundASC
was assayed by immunoblotting with anti-ASC monoclonal antibody.
Confocal microscopy. The 293T-ASC–EGFP-N1 or 293T-AIM2-ASC–EGFP-
N1 cells, orNALP32/2macrophages, were seeded on 35mm cover glass-bottom
culture dishes and allowed to attach for 24 h. The next day cells were transfected
with poly(dA:dT) (1mg per dish) for 2–3 h using Lipofectamine 2000 and then
stained with Hoechst 33342 for 30min. Cells were then observed using a Zeiss
LSM 510 Meta confocal microscope. In the experiments using the Cy3-labelled
plasmid DNA, 293T-AIM2–EGFP-N1 cells or NALP32/2-AIM2–EGFP-N1
macrophages were seeded on 35mm cover glass-bottom culture dishes and
allowed to attach for 24 h. The next day cells were transfected with Cy3-labelled
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plasmid DNA (0.5mg per dish) for 2–3 h using Lipofectamine 2000 and then
stained with Hoechst 33342 for 30min. Cells were then observed using a Zeiss
LSM 510 Meta confocal microscope. The EGFP (green) was excited with the
488 nm argon laser. The nuclear Hoechst 33342 stain (blue) was excited with the
405 nm diode laser. The Cy3 (red) was excited with the 543 nm He/Ne Laser.
In vitro caspase-1 activation and IL1b cleavage assays. Lysates containingPYD–
caspase-1 and pro-IL1b were prepared from 293T-PYD–caspase-1 or 293T-pro-
IL1b stable cell lines in CHAPS buffer (20mM HEPES-KOH, pH7.5, 5mM
MgCl2, 0.5mM EGTA, 0.1mM PMSF, 0.1% CHAPS). GST–AIM2 or ASC pyro-
ptosomes were produced in bacteria and purified by standard procedures18.
Purified GST–AIM2 or ASC pyroptosomes were incubated with PYD–caspase-
1-containing lysates together with pro-IL1b in CHAPS buffer for 60min at 37 uC.
The reaction mixtures were then fractionated by SDS–PAGE and analysed by
western blotting with anti-caspase-1 p30 and anti-IL1b antibodies. In some
experiments, in vitro translated 35S-labelled and nuclease-treated PYD–caspase-
9 (wild type or C287A) was incubated with purified GST–AIM2 or ASC pyropto-
somes in the presence or absence of poly(dA:dT) for 60min at 37 uC and the
reaction products then analysed by SDS–PAGE followed by autoradiography.
Pyroptosome isolation from poly(dA:dT) transfected macrophages.
NALP32/2 macrophages in 10 cm culture dishes were transfected with 6mg of
poly(dA:dT) or vehicle (H2O) using Lipofectamine 2000 in SF OPTI-MEM I for
4 h. The cells were then pelleted by centrifugation and then lysed in buffer A
(20mMHEPES-KOH, pH7.5, 10mMKCl, 1.5mMMgCl2, 1mM EDTA, 1mM
EGTA, 320mM sucrose, 0.1mM PMSF). ASC pyroptosomes were then isolated
from the lysates and cross-linked with DSS as described in detail recently18.
Purification and cross-linking of AIM2. Full-length AIM2 with a C-terminal
His6 tag was expressed in bacteria and then purified on Talon beads (Clontech)
according to standard procedures. Purified AIM2 (2mg) was incubated with or
without a 64-mer synthetic dsDNA (0.5 and 1 mg) for 15min at room tempera-
ture in 50ml PBS. The reaction mixtures were then cross-linked with 1 ml of 1%
glutaraldehyde, which covalently cross-links lysine residues in close proximity to
each other in oligomeric proteins. Glutaraldehyde does not cross-link proteins to
DNA. The reactions were terminated by addition of 2 ml of 2MTris-HCl, pH 8.0.
Cross-linked AIM2 was solubilized by addition of an equal volume of 23
Laemmli SDS sample buffer and fractionated on a 12.5% SDS–polyacrylamide
gel.
Statistics. All values are expressed as the mean and s.d. of individual samples.
Samples were analysed using the Student’s t-test.
17. Srinivasula, S. M. et al. The PYRIN-CARD protein ASC is an activating adaptor for
caspase-1. J. Biol. Chem. 277, 21119–21122 (2002).
18. Fernandes-Alnemri, T. & Alnemri, E. S. Chapter thirteen assembly, purification,
and assay of the activity of the ASC pyroptosome. Methods Enzymol. 442,
251–270 (2008).
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